These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38826305)

  • 41. Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer's disease-associated markers in 3xTg-AD mice.
    Kapadia M; Mian MF; Ma D; Hutton CP; Azam A; Narkaj K; Cao C; Brown B; Michalski B; Morgan D; Forsythe P; Zovkic IB; Fahnestock M; Sakic B
    Alzheimers Res Ther; 2021 Jan; 13(1):30. PubMed ID: 33472690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis.
    Guo K; Huang W; Chen K; Huang P; Peng W; Shi R; He T; Zhang M; Wang H; Hu J; Wang X; Shentu Y; Xu H; Lin L
    Aging Cell; 2023 Sep; 22(9):e13937. PubMed ID: 37503695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progressive Excitability Changes in the Medial Entorhinal Cortex in the 3xTg Mouse Model of Alzheimer's Disease Pathology.
    Chen L; Christenson Wick Z; Vetere LM; Vaughan N; Jurkowski A; Galas A; Diego KS; Philipsberg PA; Soler I; Feng Y; Cai DJ; Shuman T
    J Neurosci; 2023 Nov; 43(44):7441-7454. PubMed ID: 37714705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice.
    Mendell AL; Creighton SD; Wilson HA; Jardine KH; Isaacs L; Winters BD; MacLusky NJ
    Neuroscience; 2020 Mar; 429():185-202. PubMed ID: 31954826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F;
    J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Intracellular Amyloid-β/AβPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer's Disease.
    Esquerda-Canals G; Martí-Clúa J; Roda AR; Villegas S
    J Alzheimers Dis; 2017; 59(3):1079-1096. PubMed ID: 28697564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.
    Choi BR; Cho WH; Kim J; Lee HJ; Chung C; Jeon WK; Han JS
    Exp Mol Med; 2014 Feb; 46(2):e75. PubMed ID: 24503708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation.
    Wang WZ; Li MW; Chen Y; Liu LY; Xu Y; Xia ZH; Yu Y; Wang XD; Chen W; Zhang F; Xu XY; Gao YF; Zhang JG; Qin SC; Wang H
    J Alzheimers Dis; 2021; 82(4):1635-1649. PubMed ID: 34219730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.
    Perez SE; He B; Muhammad N; Oh KJ; Fahnestock M; Ikonomovic MD; Mufson EJ
    Neurobiol Dis; 2011 Feb; 41(2):338-52. PubMed ID: 20937383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spatial Memory and Gut Microbiota Alterations Are Already Present in Early Adulthood in a Pre-clinical Transgenic Model of Alzheimer's Disease.
    Bello-Medina PC; Hernández-Quiroz F; Pérez-Morales M; González-Franco DA; Cruz-Pauseno G; García-Mena J; Díaz-Cintra S; Pacheco-López G
    Front Neurosci; 2021; 15():595583. PubMed ID: 33994914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
    Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
    Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered Kv2.1 functioning promotes increased excitability in hippocampal neurons of an Alzheimer's disease mouse model.
    Frazzini V; Guarnieri S; Bomba M; Navarra R; Morabito C; Mariggiò MA; Sensi SL
    Cell Death Dis; 2016 Feb; 7(2):e2100. PubMed ID: 26890139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered circadian behavior and light sensing in mouse models of Alzheimer's disease.
    Weigel TK; Guo CL; Güler AD; Ferris HA
    bioRxiv; 2023 May; ():. PubMed ID: 37205532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glial cell transcriptome analyses in 3xTg-AD mice: Effects of aging, disease progression, and anti-Aβ immunotherapy.
    Lambracht-Washington D; Fu M; Manouchehri N; Hynan LS; Stuve O; Rosenberg RN
    Aging Brain; 2023; 3():100066. PubMed ID: 36911262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
    Orta-Salazar E; Aguilar-Vázquez A; Martínez-Coria H; Luquín-De Anda S; Rivera-Cervantes M; Beas-Zarate C; Feria-Velasco A; Díaz-Cintra S
    Life Sci; 2014 Oct; 116(2):83-9. PubMed ID: 25261598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer's disease.
    Vanzulli I; Papanikolaou M; De-La-Rocha IC; Pieropan F; Rivera AD; Gomez-Nicola D; Verkhratsky A; Rodríguez JJ; Butt AM
    Neurobiol Aging; 2020 Oct; 94():130-139. PubMed ID: 32619874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.